MOTS-c vs Retatrutide: Mitochondrial vs Incretin Research

MOTS-c and Retatrutide both appear in metabolic research but represent very different approaches — a mitochondrial signalling peptide versus a multi-receptor incretin agonist.

7 min read · Published 2026-06-23

MOTS-c vs Retatrutide: At a Glance

MOTS-c is a mitochondrial-derived peptide studied around the AMPK energy-sensing pathway. Retatrutide is an investigational incretin triple agonist. Both are metabolic-research compounds, but one acts at the level of mitochondrial signalling and the other at incretin/hormone receptors.

Research use only. Both compounds are supplied for in-vitro laboratory research. Neither is a medicine, and neither is for human or veterinary consumption, administration, or therapeutic use.

How They Work — The Key Difference

MOTS-c is studied as an endogenous signalling peptide that influences cellular energy metabolism via AMPK. Retatrutide is an engineered receptor agonist that activates three hormone receptors (GLP-1, GIP, glucagon). One is studied as an internal metabolic regulator; the other as an external multi-receptor agonist.

Evidence & Regulatory Status

MOTS-c research is largely preclinical with limited human data; retatrutide is investigational and in Phase 3 trials. Neither is an approved medicine in the UK, and research-grade material of either is supplied for laboratory use only.

Sourcing for Research

See our individual guides for full background, and verify purity against a batch-matched COA. View MOTS-c and Retatrutide product details.

Frequently Asked Questions

What is the difference between MOTS-c and Retatrutide?

MOTS-c is a mitochondrial-derived peptide studied around the AMPK pathway; Retatrutide is an incretin triple agonist. They act at different levels of metabolism.

Are MOTS-c or Retatrutide approved?

Neither is approved in the UK. Retatrutide is investigational; MOTS-c is a research compound. Both are research-use-only.

Why are both grouped under metabolic research?

Both are studied in metabolic contexts, but through different mechanisms — mitochondrial signalling versus incretin-receptor activation.

Related Guides

Browse research peptides or read more research guides.